Brief: Ionis Prices $700 Million Aggregate Principal Amount Of 0.00% Convertible Senior Notes Due 2030
13/11/2025 05:40
Nov 13 (Reuters) - Ionis Pharmaceuticals Inc IONS.O: IONIS PRICES CONVERTIBLE NOTES OFFERING TO REFINANCE 2026 CONVERTIBLE NOTES IONIS PHARMACEUTICALS INC: PRICING OF $700.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0.00% CONVERTIBLE SENIOR NOTES DUE 2030 Source text: ID:nBw8Wm8HZa Further company coverage: IONS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ionis Pharmaceuticals
See all newsAnalysis: US prices for new drugs fell in 2025 as fewer costly gene therapies were launched
Brief: Ionis Announces License Agreement With Recordati For Zilganersen In Alexander Disease (Axd) In All Countries Outside The U.S.
Brief: Ionis Pharmaceuticals Says FDA Approved Tryngolza For Severe Hypertriglyceridemia
Brief: FDA Approves Treatment To Reduce Risk Of Acute Pancreatitis In Adults With Severe Hypertriglyceridemia
Brief: Ionis Announces Appointment Of Ludwig Hantson, Ph.D. To Board Of Directors